FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of medicine and pharmaceuticals, namely, to a solid dispersion for oral application as a calcium channel blocker, containing an active substance and a hydrophilic carrier; according to the invention, cinnarizine in a non-crystalline form is used as an active substance, and polyethylene glycol with a molecular weight of 1,500 is used as a hydrophilic carrier, wherein the mass ratio of cinnarizine and polyethylene glycol is 1:5.
EFFECT: high solubility and stability of the active ingredient.
1 cl, 9 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL COMPOSITION COMPRISING DIFFICULTLY WATER-SOLUBLE ACTIVE SUBSTANCE SOLID SOLUTION | 2003 |
|
RU2314811C2 |
| COMPOSITION CONTAINING SOLID DISPERSION OF BAZEDOXIFENE ACETATE | 2005 |
|
RU2400227C2 |
| PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
| CAPSULES CONTAINING WATER FILLING COMPOSITIONS, STABILISED WITH DERIVATIVE OF CYCLODEXTRIN | 2003 |
|
RU2359698C2 |
| CARVEDILOL HYDROPHILIC MOLECULAR DISPERSED SOLUTION | 2001 |
|
RU2248204C2 |
| RAPIDLY DISSOLVING PHARMACEUTICAL FORM OF INDOMETHACIN AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2020 |
|
RU2764032C1 |
| INSTANTLY SOLUBLE DOSAGE FORM OF METRONIDAZOLE AND METHOD OF ITS OBTAINING (VERSIONS) | 2021 |
|
RU2797947C2 |
| SOLID DOSED OUT FORMS INCLUDING FIBRAT AND STATIN | 2004 |
|
RU2343905C2 |
| RAPIDLY DISSOLVING DOSAGE FORM OF FURAZOLIDONE AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2772430C1 |
| PRO-MEDICATION COMPOSITION FOR STRUGGLE AGAINST HEPAPATITIS C VIRUS | 2006 |
|
RU2435592C2 |
